- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the pharmacodynamic profile of a 6-month sustained-release formulation of triptorelin administered as two simultaneous subcutaneous microimplant injections (2x6 mg) by measuring serum testosterone levels.
Critère d'inclusion
- Locally advanced or metastatic prostate cancer